Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Changxin Wan(Duke University), Sarah J. Hill(Dana-Farber Cancer Institute), Michael J. Worley(Brigham and Women's Hospital), Michael G. Muto(Brigham and Women's Hospital), Matthew P. Keany(Dana-Farber Cancer Institute), Shengqing Gu(Dana-Farber Cancer Institute), Karsten Boehnke(Eli Lilly (Spain)), Colleen M. Feltmate(Brigham and Women's Hospital), Klothilda Lim(Dana-Farber Cancer Institute), Myles Brown(Harvard University), Unnati M. Pandya(Harvard University), Xiaole Shirley Liu(Dana-Farber Cancer Institute), Rui Xu(Harvard University), Christopher P. Crum(Brigham and Women's Hospital), Ursula A. Matulonis(Dana-Farber Cancer Institute), Katherine N. Lynch(Dana-Farber Cancer Institute), Henry W. Long(Dana-Farber Cancer Institute), Suzan Lazo(Dana-Farber Cancer Institute), Linah Al-Alem(Harvard University), Dominique T. Zarrella(Massachusetts General Hospital), Ross S. Berkowitz(Dana-Farber Brigham Cancer Center), Bo R. Rueda(Harvard University), Neil S. Horowitz(Brigham and Women's Hospital), Han Dong(Dana-Farber Cancer Institute), Paloma Cejas(Dana-Farber Cancer Institute), Marisa R. Nucci(Brigham and Women's Hospital), Kevin M. Elias(Harvard University)
Cited by 215
Related Papers
Model-based Analysis of ChIP-Seq (MACS)
|Genome biology|2008|20k
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Identifying ChIP-seq enrichment using MACS
|Nature Protocols|2012|2.1k
Cistrome: an integrative platform for transcriptional regulation studies
|Genome biology|2011|792
Cistrome Data Browser: a data portal for ChIP-Seq and chromatin accessibility data in human and mouse
|Nucleic Acids Research|2016|672